A study by Zhou et al.8 has indicated that inhibiting the EGFR/SRC/STAT3 signaling pathway suppresses cell proliferation, induces apoptosis, and blocks the cell cycle in the G2/M phase of gliomas. This evidence concerns the gene EGFR and central nervous system cancer.